デフォルト表紙
市場調査レポート
商品コード
1617847

感染管理市場:トランスミッション、製品、エンドユーザー別-2025-2030年の世界予測

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 185 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
感染管理市場:トランスミッション、製品、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染管理市場は、2023年に436億2,000万米ドルと評価され、2024年には457億9,000万米ドルに達すると予測され、CAGR 5.23%で成長し、2030年には623億6,000万米ドルに達すると予測されています。

感染管理は、特にヘルスケア施設において、患者と医療従事者の双方を保護するために、感染の拡大を抑制することを目的としたさまざまな政策や手順を包含しています。その範囲は、病院や診療所から地域医療や住宅ケア施設などの他の環境まで広がっており、ヘルスケアサービスの重要な側面となっています。感染管理の必要性は、COVID-19の大流行時にさらに顕著となり、手指衛生、滅菌、ワクチン接種、個人防護具の使用などの実践が強化されました。調査用途は、病院、外来手術センター、研究所など、多様な最終用途部門にまたがっています。世界の感染管理市場の主な成長決定要因としては、ヘルスケア関連感染(HAI)の有病率の上昇、滅菌・消毒技術の進歩、感染予防に対する意識の高まりと政府の取り組み、高齢者介護サービスを必要とする高齢者人口の増加などが挙げられます。シングルユース医療用不織布の需要急増、スマート感染管理管理システム、適切な感染管理アドバイスを提供する遠隔医療サービスの拡大など、大きなビジネスチャンスがあります。しかし市場は、先進的な感染管理システムの導入に関連する高コスト、地域による規制要件の違い、特に新興諸国における訓練された専門家の不足といった課題に直面しています。抗菌剤コーティングされた器具、自動滅菌システム、感染リスク評価のためのデータ駆動型予測分析に集中した技術革新は、事業の大幅な成長を促進する可能性があります。市場は現在、公衆衛生上の緊急性と技術革新の両方によってダイナミックに動いているが、感染予防に対する世界の意識が高まるにつれて競合も激化しています。コストやトレーニングに関する制約に対処する一方で、技術の強化を活用することで、感染管理ソリューションの有効性とアクセシビリティの両方に好結果をもたらすことができます。戦略的な事業運営のためには、AIやIoTを感染予防と制御に統合する技術企業との協業が競争優位性をもたらす可能性があります。

主な市場の統計
基準年【2023年 436億2,000万米ドル
推定年[2024] 457億9,000万米ドル
予測年[2030] 623億6,000万米ドル
CAGR(%) 5.23%

市場力学:急速に進化する感染管理市場の主要市場インサイトを公開

感染管理市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 院内感染発生率の上昇と感染管理製品の使用急増
    • 手術件数の増加と適切な安全方法の必要性
    • 医療機器および製薬業界における感染管理製品の採用急増
  • 市場抑制要因
    • 化学ベースの消毒剤に関連する副作用
  • 市場機会
    • 病院や診療所による滅菌サービスのアウトソーシングの増加
    • メーカーによる感染管理製品製造への投資の増加
  • 市場の課題
    • 感染管理の代替製品や代替技術の入手可能性

ポーターのファイブフォース:感染管理市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、感染管理市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:感染管理市場における外部からの影響の把握

外部マクロ環境要因は、感染管理市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析感染管理市場における競合情勢の把握

感染管理市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス感染管理市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、感染管理市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨感染管理市場における成功への道筋を描く

感染管理市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 院内感染の発生率上昇と感染管理製品の使用急増
      • 外科手術の増加と適切な安全対策の必要性
      • 医療機器・製薬業界における感染管理製品の採用急増
    • 抑制要因
      • 化学系消毒剤に伴う副作用
    • 機会
      • 病院や診療所による滅菌サービスのアウトソーシングの増加
      • 感染管理製品の製造におけるメーカーの投資増加
    • 課題
      • 感染管理の代替製品および技術の可用性
  • 市場セグメンテーション分析
    • 製品:滅菌の使用が急増し、胞子を含むあらゆる形態の微生物を除去して医療機器の安全性を確保しています。
    • エンドユーザー:病院・診療所部門における感染管理の使用法の進化
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 感染管理市場トランスミッション

  • 空中
  • ブラッドボーン
  • 契約

第7章 感染管理市場:製品別

  • 清掃と消毒
    • 消毒剤
      • 手指消毒剤
      • 器具消毒剤
      • 皮膚消毒剤
      • 表面消毒剤
    • 装置
      • フラッシャー消毒装置
      • 超音波洗浄機
      • 紫外線消毒器
      • 洗浄消毒機
    • 処方
      • 消毒スプレー
      • 消毒用ワイプ
      • 液体消毒剤
    • 消毒レベル
      • ハイレベル
      • 中級レベル
      • 低レベル
  • 内視鏡の再処理
    • 消耗品
    • 装置
  • 防護バリア
    • カバーとクロージャー
    • ゴーグル
    • 医療用不織布
  • 殺菌
    • 電子ビーム滅菌
    • 機器の滅菌
    • ETO滅菌
    • 濾過滅菌
    • ガンマ線滅菌
    • 放射線滅菌
    • 蒸気滅菌

第8章 感染管理市場:エンドユーザー別

  • 飲食品会社
  • 病院・クリニック
  • ライフサイエンス産業
  • 医療機器企業
  • 製薬会社

第9章 南北アメリカの感染管理市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の感染管理市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの感染管理市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • フロイデンベルグ・メディカル、コスタリカに第2の生産施設を設立
    • WPT Nonwovens、ケンタッキー州の製造施設に1,950万米ドルを投資し、地域経済を活性化
    • ベリーは、感染管理プロトコルで義務付けられている厳格な安全性と衛生基準を満たす軽量チューブクロージャーソリューションを発売しました。
  • 戦略分析と提言

企業一覧

  • 3M Company
  • Abbott Laboratories
  • AliMed, Inc.
  • Amway Corporation
  • Ansell Ltd.
  • ASP International GmbH
  • Becton, Dickinson and Company
  • Belimed AG
  • bioMerieux SA
  • Cantel Medical Group
  • Cardinal Health Inc.
  • Codi Group BV
  • Colgate-Palmolive Company
  • Dandong Huayang Textile and Garment Co., Ltd.
  • Diversey Holdings Ltd.
  • Ecolab Corporation
  • Embuer Health Pvt. Ltd.
  • Essity AB
  • F. Hoffmann-La Roche Ltd.
  • Getinge AB
  • Go Green Solutions, LLC
  • GOJO Industries, Inc.
  • Hartmann Group
  • Jiaxing Hongjie Commodity Co., Ltd.
  • Kao Corporation
  • Kimberly-Clark Corporation
  • Matachana Group
  • Medexter Healthcare GmbH
  • Medline Industries, LP
  • MELAG Medizintechnik GmbH & Co. KG
  • Merck KGaA
  • Metrex Research, LLC
  • Nice-Pak Products, Inc.
  • Olympus Corporation
  • Pal International Ltd.
  • Pfizer Inc.
  • Procter & Gamble Company
  • Professional Disposables International, Inc.
  • Reckitt Benckiser Group PLC
  • Rockline Industries Ltd.
  • S. C. Johnson & Son, Inc.
  • Sotera Health LLC
  • Sterigenics International LLC
  • Steris Corporation
  • Unicharm Corporation
  • Unilever PLC
  • Weiman Products, LLC
  • World Precision Instruments, LLC
  • Yessor Wipes
図表

LIST OF FIGURES

  • FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTION CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. TAIWAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 242. TAIWAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 243. TAIWAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 252. THAILAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 253. THAILAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 254. THAILAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. THAILAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. VIETNAM INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 264. VIETNAM INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 265. VIETNAM INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. VIETNAM INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 267. VIETNAM INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. DENMARK INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 287. DENMARK INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 288. DENMARK INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 289. DENMARK INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 290. DENMARK INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 297. EGYPT INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 298. EGYPT INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 299. EGYPT INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 300. EGYPT INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 301. EGYPT INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 302. EGYPT INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 308. FINLAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 309. FINLAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 310. FINLAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. FINLAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 312. FINLAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 313. FINLAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 314. FINLAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 319. FRANCE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 320. FRANCE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 321. FRANCE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. FRANCE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 323. FRANCE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 324. FRANCE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 325. FRANCE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 326. FRANCE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 330. GERMANY INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 331. GERMANY INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 332. GERMANY INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 333. GERMANY INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 334. GERMANY INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 335. GERMANY INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 336. GERMANY INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 337. GERMANY INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 338. GERMANY INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 339. ISRAEL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 340. ISRAEL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 341. ISRAEL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 342. ISRAEL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 343. ISRAEL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 344. ISRAEL INFECTION CONTROL M
目次
Product Code: MRR-43676CF42B0E

The Infection Control Market was valued at USD 43.62 billion in 2023, expected to reach USD 45.79 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 62.36 billion by 2030.

Infection control encompasses a range of policies and procedures aimed at inhibiting the spread of infections, especially in healthcare facilities, to protect both patients and healthcare workers. It's a critical dimension of healthcare services, with its scope extending from hospitals and clinics to other environments like community healthcare and residential care facilities. The necessity of infection control became even more pronounced during the COVID-19 pandemic, reinforcing practices like hand hygiene, sterilization, vaccination, and the use of personal protective equipment. Applications span across diverse end-use sectors, including hospitals, ambulatory surgical centers, research laboratories, and more. Key growth determinants for the global infection control market include the rising prevalence of healthcare-associated infections (HAIs), advancements in sterilization and disinfection technologies, heightened awareness and governmental initiatives for infection prevention, and an increased elderly population requiring aged care services. There are significant opportunities such as the surge in demand for single-use medical nonwovens, smart infection control management systems, and the expansion of telemedicine services that offer curated infection control advice. However, the market faces challenges like high costs related to implementing advanced infection control systems, variations in regulatory requirements across regions, and an inadequate number of trained professionals, particularly in developing countries. Innovations concentrated on antimicrobial-coated devices, automated sterilization systems, and data-driven predictive analytics for infection risk assessment could catalyze substantial business growth. The market is currently dynamic, being driven by both public health urgencies and technological innovations, but competition is intensifying as global awareness about infection prevention amplifies. Addressing limitations related to cost and training while capitalizing on technology enhancements can yield positive outcomes in both efficacy and accessibility of infection control solutions. For strategic business maneuvers, collaboration with tech companies to integrate AI and IoT in infection prevention and control may offer competitive advantages.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Control Market

The Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of hospital-acquired infections and surging usage of infection control products
    • Increasing number of surgical procedures and need for appropriate safety methods
    • Upsurging adoption of infection control products in medical device and pharmaceutical industry
  • Market Restraints
    • Adverse effects associated with chemical based disinfectants
  • Market Opportunities
    • Increasing outsourcing of sterilization services by hospitals, and clinics
    • Growing investments by manufacturers in the production of infection control products
  • Market Challenges
    • Availability of substitute products and techniques for infection control

Porter's Five Forces: A Strategic Tool for Navigating the Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Control Market

A detailed market share analysis in the Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Control Market

A strategic analysis of the Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Transmission, market is studied across Airborne, Bloodborne, and Contract.
  • Based on Products, market is studied across Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers, and Sterilization. The Cleaning & Disinfection is further studied across Disinfectants, Equipment, Formulation, and Level of Disinfection. The Disinfectants is further studied across Hand Disinfectants, Instrument Disinfectants, Skin Disinfectants, and Surface Disinfectants. The Equipment is further studied across Flusher Disinfectors, Ultrasonic Cleaners, UV-Ray Disinfectors, and Washer Disinfectors. The Formulation is further studied across Disinfectant Sprays, Disinfectant Wipes, and Liquid Disinfectants. The Level of Disinfection is further studied across High-Level, Intermediate-Level, and Low-Level. The Endoscope Reprocessing is further studied across Consumables and Equipment. The Protective Barriers is further studied across Covers & Closures, Goggles, and Medical Nonwovens. The Sterilization is further studied across E-Beam Sterilization, Equipment Sterilization, ETO Sterilization, Filtration Sterilization, Gamma Sterilization, Radiation Sterilization, and Steam Sterilization.
  • Based on End-User, market is studied across Food & Beverage Companies, Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
      • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
      • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with chemical based disinfectants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
      • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitute products and techniques for infection control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
    • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infection Control Market, by Transmission

  • 6.1. Introduction
  • 6.2. Airborne
  • 6.3. Bloodborne
  • 6.4. Contract

7. Infection Control Market, by Products

  • 7.1. Introduction
  • 7.2. Cleaning & Disinfection
    • 7.2.1. Disinfectants
      • 7.2.1.1. Hand Disinfectants
      • 7.2.1.2. Instrument Disinfectants
      • 7.2.1.3. Skin Disinfectants
      • 7.2.1.4. Surface Disinfectants
    • 7.2.2. Equipment
      • 7.2.2.1. Flusher Disinfectors
      • 7.2.2.2. Ultrasonic Cleaners
      • 7.2.2.3. UV-Ray Disinfectors
      • 7.2.2.4. Washer Disinfectors
    • 7.2.3. Formulation
      • 7.2.3.1. Disinfectant Sprays
      • 7.2.3.2. Disinfectant Wipes
      • 7.2.3.3. Liquid Disinfectants
    • 7.2.4. Level of Disinfection
      • 7.2.4.1. High-Level
      • 7.2.4.2. Intermediate-Level
      • 7.2.4.3. Low-Level
  • 7.3. Endoscope Reprocessing
    • 7.3.1. Consumables
    • 7.3.2. Equipment
  • 7.4. Protective Barriers
    • 7.4.1. Covers & Closures
    • 7.4.2. Goggles
    • 7.4.3. Medical Nonwovens
  • 7.5. Sterilization
    • 7.5.1. E-Beam Sterilization
    • 7.5.2. Equipment Sterilization
    • 7.5.3. ETO Sterilization
    • 7.5.4. Filtration Sterilization
    • 7.5.5. Gamma Sterilization
    • 7.5.6. Radiation Sterilization
    • 7.5.7. Steam Sterilization

8. Infection Control Market, by End-User

  • 8.1. Introduction
  • 8.2. Food & Beverage Companies
  • 8.3. Hospitals & Clinics
  • 8.4. Life Sciences Industry
  • 8.5. Medical Device Companies
  • 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
    • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
    • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. AliMed, Inc.
  • 4. Amway Corporation
  • 5. Ansell Ltd.
  • 6. ASP International GmbH
  • 7. Becton, Dickinson and Company
  • 8. Belimed AG
  • 9. bioMerieux SA
  • 10. Cantel Medical Group
  • 11. Cardinal Health Inc.
  • 12. Codi Group BV
  • 13. Colgate-Palmolive Company
  • 14. Dandong Huayang Textile and Garment Co., Ltd.
  • 15. Diversey Holdings Ltd.
  • 16. Ecolab Corporation
  • 17. Embuer Health Pvt. Ltd.
  • 18. Essity AB
  • 19. F. Hoffmann-La Roche Ltd.
  • 20. Getinge AB
  • 21. Go Green Solutions, LLC
  • 22. GOJO Industries, Inc.
  • 23. Hartmann Group
  • 24. Jiaxing Hongjie Commodity Co., Ltd.
  • 25. Kao Corporation
  • 26. Kimberly-Clark Corporation
  • 27. Matachana Group
  • 28. Medexter Healthcare GmbH
  • 29. Medline Industries, LP
  • 30. MELAG Medizintechnik GmbH & Co. KG
  • 31. Merck KGaA
  • 32. Metrex Research, LLC
  • 33. Nice-Pak Products, Inc.
  • 34. Olympus Corporation
  • 35. Pal International Ltd.
  • 36. Pfizer Inc.
  • 37. Procter & Gamble Company
  • 38. Professional Disposables International, Inc.
  • 39. Reckitt Benckiser Group PLC
  • 40. Rockline Industries Ltd.
  • 41. S. C. Johnson & Son, Inc.
  • 42. Sotera Health LLC
  • 43. Sterigenics International LLC
  • 44. Steris Corporation
  • 45. Unicharm Corporation
  • 46. Unilever PLC
  • 47. Weiman Products, LLC
  • 48. World Precision Instruments, LLC
  • 49. Yessor Wipes